Allele selective gene editing and uses thereof
AssigneeArcturus Therapeutics, Inc.
InventorsPadmanabh Chivukula, Rachel Wilkie-Grantham, Kiyoshi Tachikawa
Life of this patent
Estimating the term…
Loading patent…
AssigneeArcturus Therapeutics, Inc.
InventorsPadmanabh Chivukula, Rachel Wilkie-Grantham, Kiyoshi Tachikawa
Estimating the term…
This invention encompasses compounds, structures, compositions and methods for therapeutic guide molecules that direct CRISPR gene editing. A guide molecule for directing gene editing can be allele selective, or disease allele selective, and can exhibit reduced off target activity. A guide molecule can be composed of monomers, including UNA monomers, nucleic acid monomers, and modified nucleotides, wherein the compound is targeted to a genomic DNA. The guide molecules of this invention can be used as active ingredients for editing or disrupting a gene in vitro, ex vivo, or in vivo.
A guide compound targeted to a genomic DNA, comprising a target guide chain of 14-24 contiguous monomers attached to a crRNA, wherein the guide compound directs CRISPR gene editing of the genomic DNA, wherein the monomers comprise UNA monomers and nucleic acid monomers, and wherein the guide compound comprises a sequence of bases targeted to direct CRISPR gene editing of the genomic DNA.
Dependencies are inferred from the claim text.